Teva Pharma Industries Ltd ADR (TEVA)

10.01
-1.02(-9.25%)
After Hours
10.02
+0.01(+0.10%)
- Real-time Data
  • Volume:
    37,468,119
  • Day's Range:
    9.40 - 10.82
  • 52 wk Range:
    6.78 - 11.34
Unusual trading volume

TEVA Overview

Prev. Close
11.03
Day's Range
9.4-10.82
Revenue
15.43B
Open
10.8
52 wk Range
6.78-11.34
EPS
-0.953
Volume
37,468,119
Market Cap
11.12B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
13,819,256
P/E Ratio
-11.54
Beta
1.31
1-Year Change
5.59%
Shares Outstanding
1,110,564,656
Next Earnings Date
03 Nov 2022
What is your sentiment on Teva ADR?
or
Market is currently closed. Voting is open during market hours.

Teva Pharma Industries Ltd ADR News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Teva Pharma Industries Ltd ADR Analysis

Teva Pharma Industries Ltd ADR Company Profile

Teva Pharma Industries Ltd ADR Company Profile

Employees
35346

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company’s products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellBuyNeutral
Technical IndicatorsSellNeutralStrong SellBuyBuy
SummaryNeutralNeutralStrong SellBuyNeutral
  • dropping again. haizzzz
    0
    • Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) and ATRIPLA® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) Tablets in the U.S.
      0
      • its going up constanly. but im getting old and older also..
        0
        • 18 max
          0
          • when can we see usd60 again?
            1
            • Never!
              3
            • Perhaps soon?
              0
            • When value of USD is low enough
              0